{"id":11098,"date":"2021-03-07T14:13:33","date_gmt":"2021-03-07T14:13:33","guid":{"rendered":"http:\/\/drupal.test\/projects\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/"},"modified":"2022-07-26T13:26:17","modified_gmt":"2022-07-26T17:26:17","slug":"traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale","status":"publish","type":"project","link":"https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/","title":{"rendered":"Traduction des biomarqueurs vasculaires \u00c9quipe 2 \u2013 Fibrillation atriale"},"content":{"rendered":"<p>La d\u00e9tection et le traitement pr\u00e9coces de la fibrillation atriale sont une priorit\u00e9 pour les patients et les m\u00e9decins. La fibrillation atriale est l\u2019arythmie cardiaque la plus courante \u00e0 l\u2019\u00e9chelle mondiale, touchant plus de 25\u00a0% de la population de plus de 70\u00a0ans. Les patients atteints de fibrillation atriale sont expos\u00e9s \u00e0 un risque accru de complications, notamment d\u2019accident vasculaire c\u00e9r\u00e9bral, de troubles cognitifs, de d\u00e9mence, de paralysie et d\u2019insuffisance cardiaque. \u00c0 l\u2019heure actuelle, il n\u2019existe aucun biomarqueur \u00e9tabli pour orienter la prise en charge clinique des patients atteints de fibrillation atriale. Le pr\u00e9sent projet permettra d\u2019\u00e9tablir et de valider un panel de biomarqueurs diagnostiques li\u00e9 \u00e0 la fibrillation atriale, permettant ainsi de d\u00e9tecter de mani\u00e8re pr\u00e9coce la fibrillation atriale et de pr\u00e9dire le risque de complications. Il permettra \u00e9galement d\u2019am\u00e9liorer les soins aux patients atteints de cette maladie en pr\u00e9disant les meilleurs traitements et r\u00e9sultats. Les r\u00e9sultats de l\u2019am\u00e9lioration de la prise de d\u00e9cision dans le domaine de la fibrillation atriale devraient permettre de r\u00e9duire les co\u00fbts li\u00e9s aux soins de sant\u00e9 de plus de 200\u00a0millions de dollars par ann\u00e9e, au Canada seulement.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La d\u00e9tection et le traitement pr\u00e9coces de la fibrillation atriale sont une priorit\u00e9 pour les patients et les m\u00e9decins. La fibrillation atriale est l\u2019arythmie cardiaque la plus courante \u00e0 l\u2019\u00e9chelle mondiale, touchant plus de 25\u00a0% de la population de plus de 70\u00a0ans. Les patients atteints de fibrillation atriale sont expos\u00e9s \u00e0 un risque accru de [&hellip;]<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"project-categories":[92],"genome-competitions":[210],"project-sector":[],"genome_centres":[108],"class_list":["post-11098","project","type-project","status-publish","hentry","project-categories-translation-fr","genome-competitions-programme-de-partenariats-pour-les-applications-de-la-genomique","genome_centres-ontario-genomics-fr"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Traduction des biomarqueurs vasculaires \u00c9quipe 2 \u2013 Fibrillation atriale - GenomeCanada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Traduction des biomarqueurs vasculaires \u00c9quipe 2 \u2013 Fibrillation atriale - GenomeCanada\" \/>\n<meta property=\"og:description\" content=\"La d\u00e9tection et le traitement pr\u00e9coces de la fibrillation atriale sont une priorit\u00e9 pour les patients et les m\u00e9decins. La fibrillation atriale est l\u2019arythmie cardiaque la plus courante \u00e0 l\u2019\u00e9chelle mondiale, touchant plus de 25\u00a0% de la population de plus de 70\u00a0ans. Les patients atteints de fibrillation atriale sont expos\u00e9s \u00e0 un risque accru de [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/\" \/>\n<meta property=\"og:site_name\" content=\"GenomeCanada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-26T17:26:17+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\\\/\",\"name\":\"Traduction des biomarqueurs vasculaires \u00c9quipe 2 \u2013 Fibrillation atriale - GenomeCanada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\"},\"datePublished\":\"2021-03-07T14:13:33+00:00\",\"dateModified\":\"2022-07-26T17:26:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/project\\\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Traduction des biomarqueurs vasculaires \u00c9quipe 2 \u2013 Fibrillation atriale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"name\":\"GenomeCanada\",\"description\":\"Harnessing the transformative power of genomics\",\"publisher\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#organization\",\"name\":\"GenomeCanada\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"contentUrl\":\"https:\\\/\\\/genomecanada.ca\\\/wp-content\\\/uploads\\\/2021\\\/07\\\/genome-canada_stacked.svg\",\"width\":285,\"height\":180,\"caption\":\"GenomeCanada\"},\"image\":{\"@id\":\"https:\\\/\\\/genomecanada.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Traduction des biomarqueurs vasculaires \u00c9quipe 2 \u2013 Fibrillation atriale - GenomeCanada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/","og_locale":"fr_FR","og_type":"article","og_title":"Traduction des biomarqueurs vasculaires \u00c9quipe 2 \u2013 Fibrillation atriale - GenomeCanada","og_description":"La d\u00e9tection et le traitement pr\u00e9coces de la fibrillation atriale sont une priorit\u00e9 pour les patients et les m\u00e9decins. La fibrillation atriale est l\u2019arythmie cardiaque la plus courante \u00e0 l\u2019\u00e9chelle mondiale, touchant plus de 25\u00a0% de la population de plus de 70\u00a0ans. Les patients atteints de fibrillation atriale sont expos\u00e9s \u00e0 un risque accru de [&hellip;]","og_url":"https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/","og_site_name":"GenomeCanada","article_modified_time":"2022-07-26T17:26:17+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/","url":"https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/","name":"Traduction des biomarqueurs vasculaires \u00c9quipe 2 \u2013 Fibrillation atriale - GenomeCanada","isPartOf":{"@id":"https:\/\/genomecanada.ca\/fr\/#website"},"datePublished":"2021-03-07T14:13:33+00:00","dateModified":"2022-07-26T17:26:17+00:00","breadcrumb":{"@id":"https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/genomecanada.ca\/fr\/project\/traduction-des-biomarqueurs-vasculaires-equipe-2-fibrillation-atriale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genomecanada.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Traduction des biomarqueurs vasculaires \u00c9quipe 2 \u2013 Fibrillation atriale"}]},{"@type":"WebSite","@id":"https:\/\/genomecanada.ca\/fr\/#website","url":"https:\/\/genomecanada.ca\/fr\/","name":"GenomeCanada","description":"Harnessing the transformative power of genomics","publisher":{"@id":"https:\/\/genomecanada.ca\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genomecanada.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/genomecanada.ca\/fr\/#organization","name":"GenomeCanada","url":"https:\/\/genomecanada.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","contentUrl":"https:\/\/genomecanada.ca\/wp-content\/uploads\/2021\/07\/genome-canada_stacked.svg","width":285,"height":180,"caption":"GenomeCanada"},"image":{"@id":"https:\/\/genomecanada.ca\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/11098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project"}],"about":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/types\/project"}],"version-history":[{"count":0,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project\/11098\/revisions"}],"wp:attachment":[{"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/media?parent=11098"}],"wp:term":[{"taxonomy":"project-categories","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-categories?post=11098"},{"taxonomy":"genome-competitions","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome-competitions?post=11098"},{"taxonomy":"project-sector","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/project-sector?post=11098"},{"taxonomy":"genome_centres","embeddable":true,"href":"https:\/\/genomecanada.ca\/fr\/wp-json\/wp\/v2\/genome_centres?post=11098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}